期刊文献+

中剂量环磷酰胺治疗难治性全身型重症肌无力17例分析 被引量:2

Analysis of Median-dose Cyclophosphamide Treatment in 17 Patients with Refractory Myasthenia Gravis
下载PDF
导出
摘要 目的:探讨中剂量环磷酰胺对难治性重症肌无力(RMG)的有效性、安全性和使用方法。方法:17例RMG住院患者均采用环磷酰胺治疗30 d后,回顾性分析其发病年龄、性别、临床类型及伴发病与环磷酰胺疗效的关系。结果:治疗后随访2个月-2年(平均1年),有效率达91.3%,终点疗效与发病年龄、性别、临床类型、有无伴发胸腺瘤及手术无相关性,出现的副作用有呕吐1例、轻度白细胞计数降低5例、一过性转氨酶升高3例、脱发1例。结论:中剂量环磷酰胺治疗RMG疗效肯定,副作用少且轻微,1次治疗后症状稳定缓解可达数月。 Objective; The efficacy, side-effects, and using method of median dose cyclophosphamide (MDC) therapy in 17 patients with refractory myasthenia gravis (RMG) were analyzed. Methods; Seventeen hospitalized patients with RMG treated with MDC have been retrospectively analyzed in terms of the influence of patients' ages at onset, sex, clinical types and the accompanying disorders on efficacy of cyclophosphamide therapy. Results:During a follow-up of 0.22 years,the total effectiveness rate was 91. 3%, and the efficacy had no relation with age at onset, sex, clinical types, thymoma and thymectomy. The major side-effects ineluded vomiting, myelosuppression, increased transient alanine aminotransferase and alopecie. Conclusion; The MDC therapy appeared to be an effective and safe therapy for RMG based on the comparison after the therapy. Further case-controlled, double-blinded studies of more patients are needed to evaluate the long-term outcome in refractory generalized MG patients.
出处 《神经损伤与功能重建》 2006年第1期35-37,共3页 Neural Injury and Functional Reconstruction
关键词 重症肌无力 环磷酰胺 中剂量 myasthenia gravis cyclophosphamide
  • 相关文献

参考文献10

  • 1VINCENT A, PALACE J, JONES DH. Myasthenia Gravis[J]. Lancet (S0140 - 6736), 2001,357:2122 -2128.
  • 2DRACHMAN DB, JONES RJ, BRODSKY RA. Treatment of Refractory Myasthenia: “Rebooting”with High-dose Cyclophosphamide [J]. Ann Neurol (S0364-5134),2003,53(1) :29-34.
  • 3NIAKAN E, HARATI Y, ROLAK LA. Immunosuppressive Drug Therapy in Myasthenia Gravis [J]. Arch Neurol(S0003-9942), 1986,43(2):155-156.
  • 4杨明山 方思羽 阮旭中 主编.神经科急诊诊断治疗学[M].武汉:湖北科学技术出版社,1995.45.
  • 5OOSTERHUIS HJGH. Myasthenia Gravis[M]. London: Churchill Livingston, 1984. 46-46.
  • 6EVOLI A, BATOOCHI AP, PALMISANI MT, et al. Long term Results of Corticosteriol Therapy in Patients with Myasthenia Oravis [J]. Eur Neurol(S0022-3069), 1992,32:37-43.
  • 7GLADSTONE DE, BRANNAGAN TH, SCHWARTZMAN RJ, et al. High Dose Cyclophosphamide for Severe Refractory Myasthenia Gravis [J]. J Neurol Neurosurg Psychiatry(S0022-3050), 2004,75(5):789-791.
  • 8许贤豪.神经免疫学[M].北京:北京医科大学中国协和医科大学联合出版社,1992.113.
  • 9DEFEO LG, SCHOTTLENDER J, MARTELLI NA, et al. Use of Intravenous Pulsed Cyclophosphamide in Severe, Generalized Myasthenia Gravis [J]. Muscle Nerve(S0148-639X), 2002,26(1) :31-36.
  • 10蒋建明,涂来慧,吴涛,张仁琴,丁素菊.中小剂量环磷酰胺间隙疗法治疗重症肌无力[J].第二军医大学学报,2004,25(12):1368-1370. 被引量:8

二级参考文献1

共引文献46

同被引文献19

  • 1杨明山,卜碧涛.重症肌无力合并感染与抗生素的使用[J].临床荟萃,2004,19(21):1221-1222. 被引量:7
  • 2刘宏斌,杨光伟,梁庆成.198例胸腺切除的重症肌无力临床分析[J].国际神经病学神经外科学杂志,2005,32(4):301-303. 被引量:5
  • 3许贤豪.重症肌无力[A].见:许贤豪主编.神经免疫学[C].北京:北京医科大学.中国协和医科大学联合出版社,1992.3~13.
  • 4Khan OA, Campbell WW. Myasthenia gravis presenting as dysphagia: clinical considerations. Am J Gastroenterol, 1994,89: 1083-1085.
  • 5Llabres M, Molina-Martinez FJ, Miralles F. Dysphagia as the sole manifestation of myasthenia gravis. J Neurol Neurosurg Psychiatry, 2005, 76: 1297-1300.
  • 6杨明山.肌病//杨明山,方思羽,阮旭中.神经科急症诊断治疗学.武汉:湖北科学技术出版社,1995:410-411.
  • 7Cutolo M, Wilder RL Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am, 2000, 26:825-839.
  • 8Geuder KI, Marx A, Witzemann V, et al. C.enomic organization and lack of transcription of the nicotinic acetylcholine receptor subunits gene in myasthenia gravis-associated thymoma. Lab Invest, 1992, 66: 452-468.
  • 9Evoli A, Tonali A, Padua L, et al. Clinical correlates with anti- MuSK antibodies in generalized seronegative myasthenia gravis. Brain, 2003, 126 (Pt 10) : 2304-2311.
  • 10唐白云,杨圣艮,刘卫彬,张希,王治平,童萃文,孙培吾.甲泼尼龙联合环磷酰胺防治危重型重症肌无力术后危象[J].中山大学学报(医学科学版),2006,27(B03):213-215. 被引量:4

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部